Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
05/2006
05/18/2006US20060106216 Process for preparing the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
05/18/2006US20060106215 epoxidation, hydrolysis; purification of entecavir using a brominated styrene based resin (Diaion", AMBERLITE"); use for treating hepatitis B viral infections
05/18/2006US20060106214 3-isobutyl-8-(6-methoxy-isoquinolin-4-ylmethyl)-1-methyl-3, 7-dihydro-purine-2,6-dione; sexual dysfunction, premature labour, dysmenorrhoea, benign prostatic hyperplasia, bladder outlet obstruction, incontinence, (Prinzmetal) angina, hipotensive agent
05/18/2006US20060106037 Purin-6-one-derivatives
05/18/2006CA2585797A1 Lactam compounds and their use as pharmaceuticals
05/17/2006EP1657243A1 Procedure for the production of amino alcohols
05/17/2006EP1656378A2 Compounds and compositions as inhibitors of receptor tyrosine kinase activity
05/17/2006EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same
05/17/2006EP1423391B1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
05/17/2006EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006CN1774635A Anti-epileptogenic agents
05/16/2006US7045529 Imidazopyrimidinyl and imidazopyri dinyl derivatives
05/16/2006US7045525 Use of (R)-peniciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
05/11/2006WO2006048427A1 Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
05/11/2006US20060100429 Alkynylpurine compounds and production methods thereof
05/11/2006US20060100199 Novel condensed imidazole derivatives
05/11/2006DE102004054054A1 Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine A process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines
05/11/2006CA2586938A1 Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
05/10/2006EP1412354B1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS
05/10/2006EP1255764B1 Purine derivatives
05/10/2006EP1016407B1 Xanthine derivatives for treating brain ischemia
05/10/2006CN1771250A Xanthine derivatives as A2B adenosine receptor antagonists
05/09/2006US7041824 Such as trans-N2-(4-aminocyclohexyl)-N6-(2-aminoethyl)-1H-purine-2,6-diamine trihydrochloride for treatment/prevention of fungal diseases
05/09/2006US7041823 (Famciclovir); reacting the thallium salt of 2-aminopurine and 2-acetoxymethyl-4-bromobut-1-yl-acetate in a polar organic solvent under mild reaction conditions; selective coupling at the 9-position; by-product inhibition; antiviral drug
05/09/2006US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer
05/09/2006CA2257646C Benzo[g]quinoline derivatives
05/09/2006CA2233666C Heterocyclic fungicides
05/04/2006WO2006046024A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors
05/04/2006WO2006046023A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors
05/04/2006WO2006045828A1 Hiv inhibiting bicyclic pyrimidine derivatives
05/04/2006WO2006045565A1 Xanthine derivatives with hm74a receptor activity
05/04/2006WO2006045564A1 Xanthine derivatives with hm74a receptor activity
05/04/2006WO2006045552A1 Purine derivatives for use as adenosin a-2a receptor agonists
05/04/2006WO2005112938A3 Disalt inhibitors of il-12 production
05/04/2006US20060094870 Inosine derivatives and production methods therefor
05/04/2006US20060094733 Purine derivatives as liver x receptor agonists
05/04/2006US20060094701 Respiratory system disorders; antiinflamamtory agents; side effect reduction; administering terbutaline
05/04/2006CA2730374A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
05/04/2006CA2584904A1 Xanthine derivatives with hm74a receptor activity
05/04/2006CA2582434A1 Purine derivatives for use as adenosin a-2a receptor agonists
05/04/2006CA2577588A1 Hiv inhibiting bicyclic pyrimidine derivatives
05/03/2006EP1043021B1 Purine derivatives for the treatment of allergic diseases and systemic lupus erythematosus
05/03/2006EP0810884B1 Treatment of vascular restenosis with inhaled nitric oxide
05/02/2006US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders
05/02/2006CA2198010C 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent
04/2006
04/27/2006WO2006044573A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof
04/27/2006US20060089369 pyrimidine and pyridine derivatives; diabetes, neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency, cancer
04/27/2006DE19741739B4 Supramolekulares Paarungssystem, dessen Herstellung und Verwendung Supramolecular mating system, its preparation and use
04/27/2006CA2584209A1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof
04/26/2006EP1648895A1 Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction
04/26/2006EP1648894A1 Method for the production of oh protected [4-(2.6-diamino-9h-purine-9-yl)- 1.3-dioxolane-2-yl]methanol derivatives
04/26/2006EP1534708B1 Purine derivatives and their use as antiproliferative agents
04/26/2006EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
04/26/2006EP1210348B9 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
04/26/2006CN1763040A Abacavir production method
04/25/2006US7034152 Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
04/25/2006US7034016 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives
04/25/2006US7034014 Phosphonate compounds
04/20/2006WO2006040558A1 Substituted adenines and the use thereof
04/20/2006US20060084668 Isolated valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard
04/20/2006US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/20/2006US20060084651 Chemical compounds
04/19/2006EP1647275A1 Solid pharmaceutical preparation
04/19/2006EP1556140A4 Novel compounds
04/19/2006EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity
04/19/2006EP1253924B1 Nitrate salts of antimicrobial agents
04/19/2006EP0901474B1 Aryl pyrimidine derivatives
04/19/2006CN1252071C Xanthine Phosphodiesterase V inhibitors
04/19/2006CN1251679C Nucleotide analog composition and synthesis method
04/19/2006CN1251676C Phenyl xanthine derivative
04/18/2006US7029835 Photothermographic element comprising improved base precursors and methods for their use
04/13/2006US20060079541 e.g. 1-[(3-methyl-isoquinolin- 1 -yl)methyl]-3-methyl-7-(2-butyn- 1 -yl)-8-[(2-amino-ethyl) -methylamino]-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis
04/12/2006EP1644384A2 Process and intermediates for synthesis entecavir
04/12/2006EP1644375A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/12/2006EP1554278B1 Xanthine derivatives, production thereof and use thereof as medicines
04/12/2006EP1005356B1 Novel antibacterial agents
04/12/2006CN1250548C Novel adenine derivatives
04/12/2006CN1250224C Theobromine with anticancer activity
04/11/2006US7026310 Heteroaryl derivatives and their use as medicaments
04/06/2006WO2005113554A3 Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds
04/06/2006US20060074095 Novel purine derivatives, preparation method and use as medicines
04/06/2006US20060074056 Inhibitors of VEGF receptor and HGF receptor signaling
04/05/2006EP1244668B1 Purine derivatives, process for their preparation and use thereof
04/05/2006EP1244667B1 Cyclohexene nucleic acids
04/05/2006CN1249051C Muscarinic agonists
04/04/2006US7022851 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability
04/04/2006US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7
04/04/2006CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
03/2006
03/30/2006WO2006033703A1 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
03/30/2006WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same
03/30/2006US20060069108 Use of (R)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
03/30/2006DE102004046530A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis
03/30/2006DE102004043944A1 Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 8- (3-amino-piperidin-1-yl) -xanthines -7- (but-2-ynyl), their preparation and their use as medicaments
03/30/2006CA2580725A1 Novel heterocyclic nf-kb inhibitors
03/30/2006CA2574220A1 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 120